Skip to search formSkip to main contentSkip to account menu

abaloparatide

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Study Design: Retrospective Cohort. Objective: Establish 1-year patient-reported outcomes after spine surgery for symptomatic… 
2018
2018
ABSTRACT The recently published results of the sequential treatment of postmenopausal osteoporotic women with subcutaneous… 
Review
2018
Review
2018
Identification of patients at risk for fragility fractures is the first important step in the management of osteoporosis… 
2017
2017
Over the past decade, the osteoporosis landscape has changed. Even though more treatment options are available, fewer… 
2017
2017
Abaloparatide is a novel peptide that shares aminoterminal sequence with PTHrP. It has been shown in a clinical trial to reduce… 
2017
2017
ABSTRACT The recently published Abaloparatide Comparator Trial in Vertebral Endpoints (ACTIVE) assessed the efficacy and safety… 
Review
2017
Review
2017
ABSTRACT Introduction: Teriparatide, a PTH analogue, was the first anabolic agent to be approved for the treatment of… 
Review
2015
Review
2015
Introduction: Intermittent parathyroid hormone (PTH) administration, acting through multiple signaling pathways, exerts an…